Dr. Arndt Rolfs, CEO CENTOGENE, presented at JP Morgan Healthcare Conference 2017 about CENTOGENE's self-amplifying business model - diagnostics, proprietary tools (including the largest, fully curated mutation database for rare diseases - CentoMD®) and pharmaceutical partnerships. With patients at the center of the value chain, Dr. Rolfs explained interpretation and knowledge (big data) will be the future for genetics, which strongly related to the messages expressed at the panel discussion of diagnostics outlook at the same conference earlier, proving that CENTOGENE is in the leading position in the rare diseases field.
Dr. Arndt Rolfs presented at JP Morgan Healthcare Conference 2017
- Partnership with Parkinson’s Institute and Clinical Center
- CENTOGENE successfully renewed accreditation from College of American Pathologists